Heliantriol C
Heliantriol C is a taraxerane-type trihydroxy triterpenoid present in the ray florets of Asteraceae plants. Heliantriol C inhibits TPA (HY-18739)-induced inflammation. Heliantriol C exhibits anticancer activity, and its acetylated derivatives show enhanced cytotoxicity against cancer cells. Heliantriol C can be used in studies related to inflammation and cancers such as leukemia and lung cancer.
For research use only. We do not sell to patients.
- CAS No.: 71876-60-3
- Formula: C30H50O3
- Molecular Weight:458.73
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Heliantriol C (compound 3) (48 h) exhibits lower cytotoxicity against the human cancer cell lines HL60, A549, AZ521 and SK-BR-3 than dihydroxy taraxastane-type triterpenoids and their acetyl derivatives[2].
Heliantriol C undergoes acetylation with Ac2O in pyridine to form heliantriol C 3,16,22-tri-O-acetate (compound 25); oxidation with MnO2 in CHCl3 yields 22-oxofaradiol (compound 26)[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Heliantriol C (0.2 μmol per mouse; topical administration; administered 30 minutes before each TPA treatment, twice weekly, for 20 weeks) reduces the average number of skin tumors per mouse and decreases the proportion of tumor-bearing mice at week 20 in the DMBA/TPA two-stage mouse skin carcinogenesis model[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ICR mice (female, 7 weeks old, two-stage skin tumorigenesis model initiated by DMBA, promoted by TPA)[3]
-
Dosage:0.2 μmol per mouse
-
Administration:topical; 30 minutes before each twice-weekly TPA application; 20 weeks
-
Result:Delayed initial skin tumor onset until week 13 (control: week 8).
Lowered tumor-bearing mouse ratio to 20% at week 20 (control: 93%).
Cut average tumor count per mouse to 0.9 at week 20 (control: 8.6).
Produced obvious disparities versus control starting at week 11.
Generated distinct differences versus faradiol group from week 16 to 20.
Chemical Information
-
CAS No. 71876-60-3
-
Molecular Weight 458.73
-
Formula C30H50O3
-
SMILES
C[C@]12[C@@]([C@@]3([C@@](C)([C@@H](O)C1)[C@@H](O)C=C(C)[C@H]3C)[H])(CC[C@]4([C@@]2(C)CC[C@@]5([C@]4(C)CC[C@H](O)C5(C)C)[H])[H])[H]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)